Navigation Links
New Clinical Trial Shows Ascenta Skin Supplement Improves Skin's Resistance to UV Exposure
Date:8/7/2014

Los Angeles, CA (PRWEB) August 07, 2014

Ascenta Health is proud to announce that their revolutionary dietary supplement Ascenta Skin has been clinically shown to increase the skin’s natural protection against ultraviolet (UV) radiation, the leading cause of skin damage and accelerated skin aging.

A recent clinical trial studied the effects of UV exposure on participants who took 4 capsules of Ascenta Skin daily over an eight week period. The results were astounding! Participants displayed on average an 83.8% increase in the UV exposure needed to produce the skin reddening effect that we consider sunburn after just eight weeks.

Sunburn, or reddening of the skin, is an acute skin response to excess UV exposure. Caused by both UVA and UVB, sunburn can be painful and damaging to your skin after you have overexposed yourself to the sun. The accumulated damage accelerates skin aging characterized by an increase in sagging, wrinkling, uneven tone and sun spots. Ascenta Skin’s unique formula of 6 naturally derived active ingredients including Omega-3’s and powerful antioxidants may be the next step in sun protection from the inside out.

“Because Ascenta Skin works from the inside out it produces dramatic results not typically seen with topical skin care products. By simply adding Ascenta Skin to their current skin care regimen consumers are experiencing firmer, smoother, younger looking skin,” says Marc St-Onge, Ascenta Health CEO and creator of Ascenta Skin. “The added benefit of enhanced UV protection proves that healthy, beautiful skin starts from within.”

Conducted at Consumer Product Testing Company, a laboratory at the forefront of sun protection testing, the research featured 28 participants that completed the trial. These participants had their minimal erythemal dose (MED), the smallest dose of UV radiation that produces skin redness, recorded at the beginning of the study. After taking Ascenta Skin daily, their results were measured at the four and eight week markers.

During the first 4 weeks, their MED increased by an average of 39.1% which seemed significant until the results were in for the full eight week period. The increase after 8 weeks of 83.8% in the UV exposure needed to produce reddened skin supports the theory that Ascenta Skin has a UV protective effect on your skin.

Ascenta Skin features 6 active ingredients including DHA, EPA, GLA, Zeaxanthin, Lutein and Vitamin D. In addition to reducing the effects of UV damage, Ascenta Skin is government approved in Canada to increase skin elasticity and firmness, hydration, and reduce roughness and redness including atopic dermatitis. Ascenta Skin’s “Beauty from Within” formula is a game changer in the skin care industry, all natural, science based, amazing skin care results and now UV protection. While Ascenta Skin significantly increases your skin’s resistance to UV it is not intended as a replacement for appropriate use of topical sunscreens.

Ascenta Skin is available to purchase on AscentaSkin.com and at renowned spas throughout Canada. Coming soon to cities across America, Ascenta Skin is currently available at Space.NK.Apothecary in New York and Los Angeles.

For more information on Ascenta Skin and to see remarkable before and after images, please visit http://www.AscentaSkin.com.

Read the full story at http://www.prweb.com/releases/AscentaSkin/08/prweb12078745.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. First targeted nanomedicine to enter human clinical studies
2. Clinical insight improves treatment with new lung cancer drug
3. Clinical news alert from the American Academy of Orthopaedic Surgeons
4. NYU Langone experts present research, clinical advances at neurosurgeons meeting
5. Kroenke honored for outstanding contributions in clinical research training
6. Awards celebrate clinical research that can improve health and alleviate suffering
7. Association for Psychological Science, SAGE launch Clinical Psychological Science
8. URMC clinical trial tests new regimen for hypertension
9. Analysis Finds Clinical Trials Often Small, of Poor Quality
10. Automated insulin dosage titration system demonstrates positive clinical study results
11. Clinical news alert: Journal of the American Academy of Orthopaedic Surgeons May highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... 27, 2017 , ... Advantexe Learning Solutions , a ... a new research study, The Business Readiness Report. The report explores the correlation ... the actual success of achieving individual and company goals. , There are ...
(Date:3/27/2017)... ... 27, 2017 , ... Janet Schloz is still in shock after receiving a $2,500 Academic Award ... a long time,” she said. , She thinks the coming week is going to be ... I would have to help my students.” , The award will allow the 4th grade ...
(Date:3/27/2017)... Mt. Angel, Oregon (PRWEB) , ... March 27, ... ... supplements company, is pleased to announce the launch of a months-long rebranding effort. ... exciting new formulations. , “Through focus group discussions and market research, we learned ...
(Date:3/27/2017)... ... 27, 2017 , ... The homeowner improvement and repair market is expected to ... unlicensed contractors for renovations is also on the rise. Per a 2017 report, 13% ... those, 42% failed to use a licensed contractor.(2) The risks associated with improper renovations—especially ...
(Date:3/25/2017)... ... 25, 2017 , ... Norland at Swissray is pleased to announce the release of ... The ELITE DXA has an active scan window, which is more than double that of ... the scan area could not undergo an accurate total body bone density or body composition ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... - INVICTUS MD STRATEGIES CORP. ("Invictus MD" or the "Company") ... pleased to announce it has received conditional approval to ... Venture Exchange.  Receiving the conditional listing ... achievements for Invictus-MD. Some of which include: ... Inc. ("AB Labs"), a Licensed Producer under the Access ...
(Date:3/27/2017)... 2017  BERG, a biopharmaceutical company uncovering ... approach, today announced that the company,s Interrogative ... new data using a cold-induced model to ... Joslin Diabetes Center led the investigation with ... analysis of samples.  The findings were published ...
(Date:3/27/2017)... , March 27, 2017  iCAD (Nasdaq: ICAD), ... solutions and radiation therapy for the early identification ... Tomo Detection received Premarket Approval (PMA) from the ... Detection is a first-of-its-kind, concurrent-read computer aided detection ... the latest innovation available on the PowerLook® Breast ...
Breaking Medicine Technology: